Shakespeare Wealth Management, Inc. Abbott Laboratories Transaction History
Shakespeare Wealth Management, Inc.
- $344 Million
- Q2 2024
A detailed history of Shakespeare Wealth Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Shakespeare Wealth Management, Inc. holds 1,970 shares of ABT stock, worth $223,338. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,970
Previous 1,962
0.41%
Holding current value
$223,338
Previous $223,000
8.52%
% of portfolio
0.06%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,167Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.43 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.14 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.49 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...